Sputnik V can be kept in a standard refrigerator at 2-8 degrees Celsius, which makes it a bit easier to store than some other vaccines -- the Pfizer/BioNTech vaccine needs to be stored at minus 70 ...

Even before the negotiations start, the RDIF lists Sputnik V’s price at approximately $10 per doses — roughly half the price of the Pfizer vaccine, which costs $19.50 per dose.

Sputnik V, the Covid-19 developed by the Moscow-based Gamaleya Research Institute, was the early rising star of Covid-19 vaccines. Now it is mired in controversy arising from the institute’s ...

The interim analysis of Sputnik V came after researchers identified 20 Covid-19 cases among Phase 3 trial participants who received the vaccine or a placebo, according to a news release from the ...

Russia's Sputnik vaccine was found to be effective in preventing COVID-19 symptoms, according to a new study published in The Lancet medical journal. Here, a patient gets a shot of the Russian ...

Topline. Russia’s Sputnik V Covid-19 vaccine, which was controversially rolled out for widespread use before clinical trials had finished, has now been shown to be safe and 92% effective at ...

An interim analysis of Russia’s Sputnik V vaccine has found it to be 91.6% effective against symptomatic Covid-19 and 100% effective against severe and moderate disease.

The road to the Sputnik vaccine stretches to the 1980s, with the development of vaccines then. So when the coronavirus emerged, Gintsburg said they knew they had a solution.

Sputnik V—like several other COVID-19 vaccines, developed by Oxford University and AstraZeneca, in the United Kingdom; CanSino Biologics, in China; and Johnson & Johnson, in the United States ...

Under Russian authorities' approval, the new Sputnik Light vaccine will be marketed and given separately alongside the country's existing COVID-19 vaccines. Human testing of Sputnik Light began in ...

A single dose of the Sputnik V vaccine may elicit significant antibody responses against SARS-CoV-2, finds a study published July 13 in the journal Cell Reports Medicine.

The developer of Russia's Sputnik V vaccine says it will work on adapting it to the new omicron COVID-19 variant.